It has been about a month since the last earnings report for Bruker (BRKR). Shares have added about 17.1% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Bruker Corporation before we dive into how investors and analysts have reacted as of late.
Bruker's Q3 Earnings and Revenues Top Estimates
Bruker Corporation delivered adjusted earnings per share of 45 cents for the third quarter of 2025, down 25% year over year. However, the figure came 36.36% above the Zacks Consensus Estimate.
The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others.
Third quarter 2025 GAAP diluted loss per share was 41 cents, compared to diluted earnings per share of 27 cents in the year-ago period.
BRKR’s Q3 Revenues
Bruker's third-quarter revenues were $860.5 million, down 0.5% year over year. However, the figure topped the Zacks Consensus Estimate by 1.20%.
BRKR’s 2025 Guidance
The company has lowered its financial guidance for full-year 2025. Revenues are now expected in the range of $3.41 to $3.44 billion (previously $3.43 to $3.50 billion), suggesting 1% to 2% reported growth over 2024. The Zacks Consensus Estimate for revenues is pegged at $3.42 billion.
Adjusted earnings per share for the year is expected in the range of $1.85 to $1.90 (previously $1.95 to $2.05). The consensus estimate for the same is pegged at $1.89.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -23% due to these changes.
VGM Scores
Currently, Bruker has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Following the exact same course, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Bruker has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bruker Corporation (BRKR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
